☰

Alakananda Basu - Publications

Affiliations: 
Biochemistry and Molecular Biology University of North Texas Health Science Center at Fort Worth 
Area:
Molecular Biology, Biochemistry
Tree Info Grants Similar researchers PubMed Report error

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Basu A, Lambring CB. Akt Isoforms: A Family Affair in Breast Cancer. Cancers. 13. PMID 34298660 DOI: 10.3390/cancers13143445  0.333
2021 Basu A. The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy. Pharmacology & Therapeutics. 107943. PMID 34182005 DOI: 10.1016/j.pharmthera.2021.107943  0.48
2020 Basu A. Regulation of Autophagy by Protein Kinase C-ε in Breast Cancer Cells. International Journal of Molecular Sciences. 21. PMID 32549199 DOI: 10.3390/Ijms21124247  0.565
2020 Sridharan S, Basu A. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer. International Journal of Molecular Sciences. 21. PMID 32054043 DOI: 10.3390/Ijms21041199  0.356
2019 Dossou AS, Basu A. The Emerging Roles of mTORC1 in Macromanaging Autophagy. Cancers. 11. PMID 31554253 DOI: 10.3390/Cancers11101422  0.392
2019 Basu A. The Enigmatic Protein Kinase C-eta. Cancers. 11. PMID 30781807 DOI: 10.3390/Cancers11020214  0.495
2018 Basu A, Pal D, Blaydes R. Differential effects of protein kinase C-eta on apoptosis versus senescence. Cellular Signalling. 55: 1-7. PMID 30562553 DOI: 10.1016/J.Cellsig.2018.12.003  0.601
2017 Pal D, Basu A. Protein kinase C-eta regulates Mcl-1 level via ERK1. Cellular Signalling. PMID 28939105 DOI: 10.1016/J.Cellsig.2017.09.012  0.574
2017 Basu A, Sridharan S. Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2. Plos One. 12: e0173854. PMID 28301598 DOI: 10.1371/Journal.Pone.0173854  0.644
2016 Gdowski A, Panchoo M, Treuren TV, Basu A. Emerging therapeutics for targeting Akt in cancer. Frontiers in Bioscience (Landmark Edition). 21: 757-68. PMID 26709804 DOI: 10.2741/4419  0.475
2014 Pal D, Basu A. The unique protein kinase Cη: implications for breast cancer (review). International Journal of Oncology. 45: 493-8. PMID 24841225 DOI: 10.3892/Ijo.2014.2443  0.409
2014 Jain K, Basu A. The Multifunctional Protein Kinase C-ε in Cancer Development and Progression. Cancers. 6: 860-78. PMID 24727247 DOI: 10.3390/Cancers6020860  0.433
2013 Pal D, Outram SP, Basu A. Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival. Biochimica Et Biophysica Acta. 1830: 4040-5. PMID 23562764 DOI: 10.1016/J.Bbagen.2013.03.028  0.485
2013 Sehrawat A, Yadav S, Awasthi YC, Basu A, Warden C, Awasthi S. P300 regulates the human RLIP76 promoter activity and gene expression. Biochemical Pharmacology. 85: 1203-11. PMID 23419874 DOI: 10.1016/J.Bcp.2013.02.012  0.335
2013 Sridharan S, Basu A. Abstract 838: Distinct effects of S6K homologues on breast cancer cell survival. Cancer Research. 73: 838-838. DOI: 10.1158/1538-7445.Am2013-838  0.566
2012 Pal D, Outram SP, Basu A. Novel regulation of protein kinase C-η. Biochemical and Biophysical Research Communications. 425: 836-41. PMID 22892130 DOI: 10.1016/J.Bbrc.2012.07.163  0.483
2011 Sridharan S, Jain K, Basu A. Regulation of autophagy by kinases. Cancers. 3: 2630-54. PMID 24212825 DOI: 10.3390/Cancers3022630  0.485
2011 Krishnamurthy S, Basu A. Regulation of IKKε Expression by Akt2 Isoform. Genes & Cancer. 2: 1044-50. PMID 22737270 DOI: 10.1177/1947601912444604  0.491
2011 Sridharan S, Basu A. S6 kinase 2 promotes breast cancer cell survival via Akt. Cancer Research. 71: 2590-9. PMID 21427355 DOI: 10.1158/0008-5472.Can-10-3253  0.607
2010 Basu A, Pal D. Two faces of protein kinase Cδ: the contrasting roles of PKCδ in cell survival and cell death. Thescientificworldjournal. 10: 2272-84. PMID 21103796 DOI: 10.1100/Tsw.2010.214  0.578
2010 Basu A, Krishnamurthy S. Cellular responses to Cisplatin-induced DNA damage. Journal of Nucleic Acids. 2010. PMID 20811617 DOI: 10.4061/2010/201367  0.504
2010 Shankar E, Basu C, Adkins B, Siede W, Basu A. NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner. Journal of Molecular Signaling. 5: 4. PMID 20459745 DOI: 10.1186/1750-2187-5-4  0.473
2010 Shankar E, Krishnamurthy S, Paranandi R, Basu A. PKCepsilon induces Bcl-2 by activating CREB. International Journal of Oncology. 36: 883-8. PMID 20198332 DOI: 10.3892/Ijo_00000566  0.597
2010 Jain D, Patel N, Shelton M, Basu A, Roque R, Siede W. Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression. Cancer Chemotherapy and Pharmacology. 66: 945-52. PMID 20101404 DOI: 10.1007/S00280-010-1246-8  0.416
2009 Basu A, Sridharan S, Persaud S. Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2. Cellular Signalling. 21: 1680-5. PMID 19632318 DOI: 10.1016/J.Cellsig.2009.07.006  0.757
2009 Dhar R, Persaud SD, Mireles JR, Basu A. Proteolytic cleavage of p70 ribosomal S6 kinase by caspase-3 during DNA damage-induced apoptosis. Biochemistry. 48: 1474-80. PMID 19191576 DOI: 10.1021/Bi801840S  0.786
2008 Basu A, Persaud SD, Sivaprasad U. Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs. Methods in Enzymology. 446: 141-57. PMID 18603120 DOI: 10.1016/S0076-6879(08)01608-X  0.765
2008 Dhar R, Basu A. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin. International Journal of Oncology. 32: 1133-7. PMID 18425342 DOI: 10.3892/Ijo.32.5.1133  0.63
2008 Basu A, Adkins B, Basu C. Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway. Cancer Research. 68: 2795-802. PMID 18413747 DOI: 10.1158/0008-5472.Can-07-6244  0.574
2008 Shankar E, Sivaprasad U, Basu A. Protein kinase Cε confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53 Oncogene. 27: 3957-3966. PMID 18317451 DOI: 10.1038/Onc.2008.39  0.522
2008 Sivaprasad U, Basu A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-α-induced cell death in MCF-7 cells Journal of Cellular and Molecular Medicine. 12: 1265-1271. PMID 18266953 DOI: 10.1111/J.1582-4934.2008.00282.X  0.585
2007 Lu D, Sivaprasad U, Huang J, Shankar E, Morrow S, Basu A. Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation. Apoptosis : An International Journal On Programmed Cell Death. 12: 1893-900. PMID 17668322 DOI: 10.1007/S10495-007-0111-7  0.61
2007 Basu A, Sivaprasad U. Protein kinase Cepsilon makes the life and death decision. Cellular Signalling. 19: 1633-42. PMID 17537614 DOI: 10.1016/J.Cellsig.2007.04.008  0.548
2007 Sivaprasad U, Shankar E, Basu A. Downregulation of Bid is associated with PKC ɛ -mediated TRAIL resistance Cell Death & Differentiation. 14: 851-860. PMID 17186022 DOI: 10.1038/Sj.Cdd.4402077  0.601
2006 Lu D, Huang J, Basu A. Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. The Journal of Biological Chemistry. 281: 22799-807. PMID 16785234 DOI: 10.1074/Jbc.M603390200  0.601
2005 Mohanty S, Huang J, Basu A. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6730-7. PMID 16166454 DOI: 10.1158/1078-0432.CCR-05-0450  0.525
2005 Basu A, Tu H. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochemical and Biophysical Research Communications. 334: 1068-73. PMID 16039614 DOI: 10.1016/J.Bbrc.2005.06.199  0.612
2005 Persaud SD, Hoang V, Huang J, Basu A. Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells. International Journal of Oncology. 27: 149-54. PMID 15942654  0.791
2005 Persaud SD, Hoang V, Huang J, Basu A. Involvement of proteolytic activation of PKCδ in cisplatin-induced apoptosis in human small cell lung cancer H69 cells International Journal of Oncology. 27: 149-154. DOI: 10.3892/Ijo.27.1.149  0.789
2004 Lu D, Huang J, Basu A. Deregulation of PKB influences antiapoptotic signaling by PKC in breast cancer cells. International Journal of Oncology. 25: 671-6. PMID 15289868 DOI: 10.3892/Ijo.25.3.671  0.59
2004 Huang J, Mohanty S, Basu A. Cisplatin resistance is associated with deregulation in protein kinase C-delta. Biochemical and Biophysical Research Communications. 316: 1002-8. PMID 15044084 DOI: 10.1016/J.Bbrc.2004.02.149  0.599
2004 Kumar Biswas S, Huang J, Persaud S, Basu A. Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. Molecular Cancer Therapeutics. 3: 327-34. PMID 15026553  0.771
2003 Basu A. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. Journal of Cellular and Molecular Medicine. 7: 341-50. PMID 14754503 DOI: 10.1111/J.1582-4934.2003.Tb00237.X  0.512
2002 Johnson CL, Lu D, Huang J, Basu A. Regulation of p53 stabilization by DNA damage and protein kinase C. Molecular Cancer Therapeutics. 1: 861-7. PMID 12492119  0.446
2002 Basu A, Miura A. Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C. International Journal of Molecular Medicine. 10: 541-5. PMID 12373288 DOI: 10.3892/Ijmm.10.5.541  0.622
2002 Basu A, Lu D, Sun B, Moor AN, Akkaraju GR, Huang J. Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals. The Journal of Biological Chemistry. 277: 41850-6. PMID 12198125 DOI: 10.1074/Jbc.M205997200  0.569
2002 Basu A, Johnson DE, Woolard MD. Potentiation of tumor necrosis factor-alpha-induced cell death by rottlerin through a cytochrome-C-independent pathway. Experimental Cell Research. 278: 209-14. PMID 12169276 DOI: 10.1006/Excr.2002.5587  0.573
2001 Basu A, Akkaraju GR. Compartmentalized protein kinase C activation in ovarian carcinoma cells. Methods in Molecular Medicine. 39: 621-31. PMID 21340822 DOI: 10.1385/1-59259-071-3:621  0.394
2001 Basu A, Woolard MD, Johnson CL. Involvement of protein kinase C-δ in DNA damage-induced apoptosis Cell Death and Differentiation. 8: 899-908. PMID 11526445 DOI: 10.1038/Sj.Cdd.4400885  0.584
2001 Basu A, Mohanty S, Sun B. Differential Sensitivity of Breast Cancer Cells to Tumor Necrosis Factor-α: Involvement of Protein Kinase C Biochemical and Biophysical Research Communications. 280: 883-891. PMID 11162606 DOI: 10.1006/Bbrc.2000.4209  0.532
2000 Akkaraju GR, Basu A. Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death. Biochemical and Biophysical Research Communications. 279: 103-7. PMID 11112424 DOI: 10.1006/Bbrc.2000.3903  0.6
1999 Basu A, Akkaraju GR. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry. 38: 4245-51. PMID 10194341 DOI: 10.1021/Bi982854Q  0.589
1992 Basu A, Kozikowski AP, Lazo JS. Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C Biochemistry. 31: 3824-3830. PMID 1567838 DOI: 10.1021/bi00130a013  0.323
Show low-probability matches.